American Shared Hospital Services (AMS): Total Liabilities
$27.79M
As of 2025-12-31
$26.68M
As of 2026-06-30
+14.9%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $27.79M | -7.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $30.17M | +37.9% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $21.88M | +19.4% | 2025-04-04, Balance as of period end |
| 2022-12-31 | $18.33M | -13.5% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $21.19M | n/a | 2023-03-31, Balance as of period end |
| No annual figure between 2014-12-31 and 2021-12-31. | |||
| 2014-12-31 | $19.37M | -20.6% | 2015-04-01, Balance as of period end |
| 2013-12-31 | $24.38M | n/c | 2015-04-01, Balance as of period end |
| 2012-12-31 | $45.21M | n/a | 2014-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $72.98M | +8.4% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $637.9K | -69.8% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $344.15M | -28.3% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $152.55M | +13.6% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $106.81M | +17.6% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
Compare AMS, XGN, PSNL, BDSX side by side · Screen every company in Services-Medical Laboratories ↗